Skip to main content

  • Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction

    • Posted: 02/28/2022
    • Author:

      Hui Wen Sim, Elizabeth H. Thong, Andie H. Djohan, Jason Z. Chen, Joon Sin Ser, Poay Huan Loh, Chi-Hang Lee, Mark Y. Chan, Adrian F. Low, Edgar L. Tay, Koo Hui Chan, Huay Cheem Tan and Joshua P. Loh

    • CRM2022

    Abstract

    Background

    Biodegradable polymer drug eluting stents (BP-DES) may offer the advantage of vascular healing in ST-segment elevation myocardial infarction (STEMI). Long-term outcome data comparing BP-DES and second-generation durable polymer drug eluting stents (DP-DES) in STEMI is lacking. This study aims to compare the long-term clinical outcomes of BP-DES versus second-generation DP-DES in STEMI.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details